Yuhong Ding

Yuhong Ding

Auto-generated profile, based on publicly available information

Yuhong Ding


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2022 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PHPan Hong
Pan Hong
RLRuikang Liu
Ruikang Liu
SRSaroj Rai
Saroj Rai
JLJiaJia Liu
JiaJia Liu
YDYuhong Ding
Yuhong Ding
JLJin Li
Jin Li
Background: Tranexamic acid (TXA) has been applied in various types of surgery for hemostasis purposes. The efficacy and safety of TXA are still controversial in different surgeries. Guidelines for clinical application of TXA are needed.Materials and method: We systematically searched multiple medical databases for meta-analyses examining the efficacy and safety of TXA. Types of surgery included joint replacement surgery, other orthopedic surgeries, cardiac surgery, cerebral surgery, etc. Outcomes were blood loss, blood transfusion, adverse events, re-operation rate, operative time and length of hospital stay, hemoglobin (Hb) level, and coagulation function. Assessing the methodological quality of systematic reviews 2 (AMSTAR 2) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) were used for quality assessment of the included meta-analyses. Overlapping reviews were evaluated by calculating the corrected covered area (CCA).Result: In all, we identified 47 meta-analyses, of which 44 of them were of “high” quality. A total of 319 outcomes were evaluated, in which 58 outcomes were assessed as “high” quality. TXA demonstrates significant hemostatic effects in various surgeries, with lower rates of blood transfusion and re-operation, shorter operative time and length of stay, and higher Hb levels. Besides, TXA does not increase the risk of death and vascular adverse events, but it is a risk factor for seizure (a neurological event) in cardiac surgery.Conclusion: Our study demonstrates that TXA has a general hemostatic effect with very few adverse events, which indicates TXA is the recommended medication to prevent excessive bleeding and reduce the blood transfusion rate. We also recommend different dosages of TXA for different types of adult surgery. However, we could not recommend a unified dosage for different surgeries due to the heterogeneity of the experimental design.Systematic Review Registration:clinicaltrials.gov/, identifier CRD42021240303

24 May 2024 in International Journal of Surgery
Verified
Journal Article
Open access
LLLilong Liu
Lilong Liu
KLKaiwen Li
Kaiwen Li
Shaogang WangShaogang Wang
Shaogang Wang
CCChinese Bladder Cancer Consortium
Chinese Bladder Cancer Consortium
JWJianli Wang
Jianli Wang
KCKe Chen
Ke Chen
Objective: Most bladder cancers are nonmuscle invasive bladder cancer (NMIBC), and transurethral resection of bladder tumors (TURBT) is the standard treatment. However, postoperative recurrence remains a significant challenge, and the influence of bladder tumor location on prognosis is still unclear. This study aims to investigate how tumor location affects the prognosis of NMIBC patients undergoing TURBT and to identify the optimal surgical approach. Methods: A multicenter study was conducted, which included Chinese NMIBC data from 15 hospitals (1996–2019) and data from 17 registries of the Surveillance, Epidemiology, and End Results database (SEER) (2000–2020). Patients initially diagnosed with NMIBC and undergoing TURBT or partial cystectomy were analyzed, with cases lost to follow-up or with missing data excluded. The study investigated the overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) among patients with different tumor locations. Kaplan–Meier, Cox regression, and propensity score matching methods were employed to explore the association between tumor location and prognosis. Stratified populations were analyzed to minimize bias. Results: This study included 118 477 NMIBC patients and highlighted tumor location as a crucial factor impacting post-TURBT prognosis. Both anterior wall and dome tumors independently predicted adverse outcomes in two cohorts. For anterior wall tumors, the Chinese cohort showed hazard ratios (HR) for OS of 4.35 (P<0.0001); RFS of 2.21 (P<0.0001); SEER cohort OS HR of 1.10 (P=0.0001); DSS HR of 1.13 (P=0.0183). Dome tumors displayed similar trends [Chinese NMIBC cohort OS HR of 7.91 (P<0.0001); RFS HR of 2.12 (P<0.0001); SEER OS HR of 1.05 (P=0.0087); DSS HR of 1.14 (P=0.0006)]. Partial cystectomy significantly improved the survival of dome tumor patients compared to standard TURBT treatment (P<0.01). Conclusion: This study reveals the significant impact of tumor location in NMIBC patients on the outcomes of TURBT treatment, with tumors in the anterior wall and bladder dome showing poor post-TURBT prognosis. Compared to TURBT treatment, partial cystectomy improves the prognosis for bladder dome tumors. This study provides guidance for personalized treatment and prognosis management for NMIBC patients.

27 November 2024 in Genes
Verified
Journal Article
Open access
PDF file
LLLilong Liu
Lilong Liu
ZYZhipeng Yao
Zhipeng Yao
YLYiting Liu
Yiting Liu
YLYang Li
Yang Li
YDYuhong Ding
Yuhong Ding
YHYaxin Hou
Yaxin Hou
Objectives: B7 homolog 3 protein (B7-H3, also known as CD276) is a member of the B7 family that has been found to be associated with the growth and progression of a variety of tumors, but no pan-cancer evaluations of CD276 have been performed so far. In this study, we aimed to perform a pan-cancer analysis of the oncogenic role of CD276 in human tumors; Methods: We used a series of databases to perform a pan-cancer analysis of CD276, including the expression level of CD276 in pan-cancer and its relationship to tumor progression, patient survival duration, the immune cell infiltration within the tumor, and the potential signaling pathways and molecular mechanisms associated with CD276; Results: We found that CD276 was a potential biomarker for the prognosis of most cancers. The high expression of CD276 was associated with tumor progression, leading to poor survival. Notably, the up-regulation of CD276 expression in tumors increased the tumor infiltration of cancer-associated fibroblasts (CAFs) and myeloid-derived suppressor cells (MDSCs) and decreased the CD8+ T cells; Conclusions: Our study demonstrates that CD276 might promote tumor progression via the promotion of an immunosuppressive microenvironment.

12 March 2021 in Medicine
Verified
Journal Article
Open access
JLJin Li
Jin Li
XZXiaolong Zhao
Xiaolong Zhao
Saroj RaiSaroj Rai
Saroj Rai
YDYuhong Ding
Yuhong Ding
QZQi Zhang
Qi Zhang
PHPan Hong
Pan Hong
A neglected Monteggia fracture is defined as the fracture of the proximal ulna associated with radial head dislocation (RHD) without undergoing any treatment for 4 weeks or more after injury. One-stage operation of ulnar corrective osteotomy and open reduction of RHD might result in many complications. Therefore, a two-stage strategy, including ulnar osteotomy (UO) with or without annular ligament reconstruction (ALR), was adopted at our institute since 2010. We performed a retrospective review of 51 patients with neglected Monteggia fracture between January 2010 and January 2018. Patients with bilateral problems or concomitant injuries in the ipsilateral extremity were excluded. Radiological and clinical data were collected from Hospital Database and clinical visits. All patients were divided into 2 groups based on the status of the ALR: the UO alone (UO) group and the ALR group. There were 15 patients in the UO group and 36 patients in the ALR group. The age in the UO group (6.1 ± 2.3, year) was significantly younger than the ALR group (9.8 ± 2.8, year) (P < .001). Concerning the duration from initial injury to surgery, there was a significant difference between the UO group (8.6 ± 3.2 months) and the ALR group (23.3 ± 12.6 months, P < .001). Concerning the preoperative elbow function, there was no significant difference between the UO group (67.6 ± 5.0) and the ALR group (66.6 ± 4.4) according to the Mayo elbow performance score (MEPS) (P = .51). Concerning the postoperative parameters, including postoperative ROM of the joint, removal of external fixator (6.7 ± 0.8, 6.9 ± 0.9 weeks) (P = .55), lengthening (8.9 ± 2.5, 10.3 ± 2.5 mm) (P = .10) and MEPS (92.7 ± 2.1, 91.6 ± 2.1) (P = .08), there was no significant difference between the UO group and ALR group. Two-stage strategy is a reasonable choice for selected patients with long-lasting RHD with ulnar deformity.

29 January 2023 in Medicina
Verified
Journal Article
Open access
PDF file
PHPan Hong
Pan Hong
YDYuhong Ding
Yuhong Ding
RXRuijing Xu
Ruijing Xu
Saroj RaiSaroj Rai
Saroj Rai
RLRuikang Liu
Ruikang Liu
JLJin Li
Jin Li
Background: Various techniques have been reported to treat large, segmental tibial defects, such as autogenous bone graft, vascularized free fibula transfer and bone transport. We present a case of a 24-year-old male with a 17-year history of chronic osteomyelitis with obvious lower limb length discrepancy and severe varus deformity of the tibia secondary to osteomyelitis in childhood. Aim: The aim of this work is to provide an alternative choice for treating patients in developing countries with severe lower limb deformity caused by chronic osteomyelitis. Case Presentations: Without surgical intervention for a prolonged period of time, the patient was admitted in our institute for corrective surgery. Corrective surgery consisted of three stages: lengthening with Ilizarov frame, removal of Ilizarov frame and fixation with externalized locking plate, and removal of externalized locking plate. Tibia bridging was achieved at the distal and proximal junction. The range of motion (ROM) of the knee joint was nearly normal, but the stiffness of the ankle joint was noticeable. The remaining leg discrepancy of 0.1 cm required no application of a shoe lift. Moreover, the patient could engage in daily activities without noted limping. Conclusions: Distraction–compression osteogenesis using the Ilizarov apparatus is a powerful tool to lengthen the shortened long bone and adjust the deformity of the lower limbs. Externalized locking plates provide an alternative to the traditional bulky external fixator, as its low profile makes it more acceptable to patients without compromising axial and torsional stiffness. In all, a combination of Ilizarov frame, externalized locking plate and tibia bridging is an alternative for patients in similar conditions.

5 June 2025 in Bladder
Verified
Journal Article
Open access
PDF file
YLYiting Liu
Yiting Liu
LLLilong Liu
Lilong Liu
ZYZhipeng Yao
Zhipeng Yao
YHYaxin Hou
Yaxin Hou
ZLZhenghao Liu
Zhenghao Liu
KCKe Chen
Ke Chen
Background: Bladder cancer (BCa) represents a common malignancy of the urinary system across the globe and poses significant treatment challenges. Objective: This review comprehensively examined the application of laser technology in the treatment of BCa, including thulium (Tm) lasers (e.g., Tm-doped yttrium aluminium garnet [YAG]), GreenLight lasers (e.g., potassium titanyl phosphate-doped YAG and lead aluminum borate-doped YAG), holmium lasers (e.g., Ho-doped YAG), Tm fiber laser (TFL), and diode lasers. Studies have demonstrated that laser technology effectively improves tumor resection quality, reduces intraoperative bleeding, shortens recovery time, and lowers recurrence rates. Among these, Ho-doped YAG and Tm-doped YAG lasers have been shown to reduce tissue damage and enhance resection precision, while the TFL has attracted attention for its efficient tissue cutting and minimal thermal damage. GreenLight lasers offer advantages in preserving surrounding healthy tissues and demonstrate potential for use in outpatient settings. Diode lasers, known for their high-energy efficiency, contribute to improved overall treatment efficacy. This article further explored the benefits, drawbacks, and prospective uses of each laser technology in BCa treatment. Conclusion: This article thoroughly reviewed the applications of various laser technologies in BCa treatment, highlight their benefits and limitations, and assess their potential roles in future clinical practice.